StockNow
Calendar
Log in
Global Markets

Novo Nordisk (NOVOB DC) says obesity cannot be addressed with only one or two products; Co. plans to segment the patient population and expand its portfolio across injectable and oral therapies

StockNow breaking-news AI analysis

Novo Nordisk plans to segment patients and expand into injectable and oral obesity therapies, while management emphasized that Ozempic's global market-share pressure must be reversed.

News detail

Management says Ozempic’s global market-share pressure must be reversed.

1 stocks
NVONovo-Nordisk A/S$38.10Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Politics

Air Force jets have been scrambled to intercept a plane taking off from Dubai to Tel Aviv, N12/N13; plane sent out a distress signal, a "hijacking code" was entered according to journalist Shemesh. Following the signal, the plane has not been in contact.

Geopolitics

Flight FDB1073 is no longer available on tracking apps

Geopolitics

"The plane changed direction back to Israel but will not be allowed to land here until it is clear what is happening on board", N12